What antibiotics are recommended for treating diverticulitis, including uncomplicated disease and abscess formation?

Antibiotic Recommendations for Diverticulitis

For uncomplicated diverticulitis in immunocompetent patients, antibiotics are NOT routinely recommended—conservative management without antibiotics is the preferred approach. 1

Treatment Algorithm by Clinical Scenario

Uncomplicated Diverticulitis

Immunocompetent, non-critically ill patients:

• No antibiotics needed for CT-confirmed uncomplicated acute diverticulitis 1, 2
• Conservative management with observation, pain control, and dietary modification (clear liquids initially)

High-risk patients requiring antibiotics (≤7 days):

• Immunocompromised/aged patients 1
• Persistent fever or chills
• Increasing leukocytosis
• Age >80 years
• Pregnancy
• Chronic conditions (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes) 3

Outpatient antibiotic regimens:

• First-line: Oral amoxicillin-clavulanate OR cefalexin + metronidazole 3
• Alternative: Oral fluoroquinolone + metronidazole 4
• Duration: 4-7 days 1

Complicated Diverticulitis with Abscess

Small diverticular abscesses:

• Antibiotic therapy alone for 7 days 1

Large diverticular abscesses:

• Percutaneous drainage + antibiotics for 4 days (if drainage successful) 1
• If drainage not feasible in immunocompetent, non-critically ill: antibiotics alone may be considered
• If drainage not feasible in critically ill/immunocompromised: surgical intervention 1

Critically Ill or Immunocompromised Patients

With adequate source control:

• Piperacillin/tazobactam: 6 g/0.75 g loading dose, then 4 g/0.5 g q6h OR 16 g/2 g continuous infusion 1
• OR Eravacycline: 1 mg/kg q12h 1
• Duration: 4 days if immunocompetent/non-critically ill; up to 7 days if immunocompromised/critically ill 1

With inadequate/delayed source control or ESBL risk:

• Ertapenem: 1 g q24h 1
• OR Eravacycline: 1 mg/kg q12h 1

If septic shock:

• Meropenem: 1 g q6h by extended/continuous infusion 1
• OR Doripenem: 500 mg q8h by extended/continuous infusion 1
• OR Imipenem/cilastatin: 500 mg q6h by extended infusion 1
• OR Eravacycline: 1 mg/kg q12h 1

Beta-lactam allergy:

• Eravacycline: 1 mg/kg q12h 1
• OR Tigecycline: 100 mg loading dose, then 50 mg q12h 1

Inpatient Management (Unable to Tolerate Oral Intake)

Intravenous options:

• Cefuroxime or ceftriaxone + metronidazole 3
• Ampicillin/sulbactam 3
• Piperacillin-tazobactam 3

Key Clinical Considerations

Common pitfalls to avoid:

• Do NOT routinely prescribe antibiotics for uncomplicated diverticulitis in low-risk patients—this represents overtreatment and contributes to antibiotic resistance 2, 5, 6
• Do NOT rely solely on clinical examination for diagnosis; CT imaging is essential for first presentation and when complications are suspected 7, 2
• Do NOT delay antibiotics in immunocompromised patients, who present with milder symptoms but higher complication risk 4

Predictors of progression to complicated disease:

• Symptoms >5 days
• Vomiting
• C-reactive protein >140 mg/L (or >50 mg/L in some studies)
• CT findings: pericolic extraluminal air, fluid collection, or longer inflamed segment (>86 mm) 4, 2

Duration considerations:

• Patients with ongoing infection/systemic illness beyond 7 days warrant diagnostic investigation 1
• Immunocompromised patients recovering from diverticulitis should consult colorectal surgery regarding elective resection 4

The 2024 Italian guidelines 1 represent the most recent high-quality evidence and emphasize a conservative, selective approach to antibiotics that aligns with the pathophysiology of diverticulitis as primarily inflammatory rather than infectious 2. This approach reduces unnecessary antibiotic exposure while maintaining safety in appropriately selected patients.